ARTICLE | Company News
Advancell, Helsinn deal
July 15, 2013 7:00 AM UTC
Advancell granted Helsinn exclusive, worldwide rights to develop and commercialize ATH008. The undisclosed topical cream is in development to treat palmoplantar erythrodysesthesia syndrome (PPES) and...